Cargando…

Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients

Unfractionated heparin (UFH) is currently the standard anticoagulant used in extracorporeal life support (ECLS). However, severe thrombocytopenia occurs frequently during ECLS use and it may be difficult to determine whether this represents heparin-induced thrombocytopenia (HIT) or not. In this case...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Young Su, Lee, Heemoon, Yang, Ji-Hyuk, Sung, Kiick, Suh, Gee Young, Chung, Chi Ryang, Yang, Jeong Hoon, Cho, Yang Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393155/ https://www.ncbi.nlm.nih.gov/pubmed/30461625 http://dx.doi.org/10.1097/MD.0000000000013235

Ejemplares similares

Use of extracorporeal membrane oxygenation in postpartum patients with refractory shock or respiratory failure
por: Ko, Ryoung-Eun, et al.
Publicado: (2021)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

The Use of Extracorporeal Circulation in Suspected Brain Dead Organ Donors with Cardiopulmonary Collapse
por: Lee, Hyun, et al.
Publicado: (2015)

Refractory Ventricular Arrhythmia Induced by Aconite Intoxication and Its Treatment with Extracorporeal Cardiopulmonary Resuscitation
por: Hong, Mi Kyoung, et al.
Publicado: (2017)

The effect of multidisciplinary extracorporeal membrane oxygenation team on clinical outcomes in patients with severe acute respiratory failure
por: Na, Soo Jin, et al.
Publicado: (2018)

Prognostic Value of Early Intermittent Electroencephalography in Patients after Extracorporeal Cardiopulmonary Resuscitation
por: Kim, Yong Oh, et al.
Publicado: (2020)

Inter-Facility Transport on Extracorporeal Life Support: Clinical Outcomes and Comparative Analysis with In-house Patients
por: Hong, Tae Hee, et al.
Publicado: (2017)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

Outcomes of Coronary Artery Bypass Grafting after Extracorporeal Life Support in Patients with Cardiac Arrest or Cardiogenic Shock
por: Kim, Younghwan, et al.
Publicado: (2019)

Erratum: Inter-Facility Transport on Extracorporeal Life Support: Clinical Outcomes and Comparative Analysis with In-house Patients
por: Hong, Tae Hee, et al.
Publicado: (2017)

Association of body mass index with clinical outcomes for in-hospital cardiac arrest adult patients following extracorporeal cardiopulmonary resuscitation
por: Gil, Eunmi, et al.
Publicado: (2017)

Association between Body Temperature Patterns and Neurological Outcomes after Extracorporeal Cardiopulmonary Resuscitation
por: Ryu, Jeong-Am, et al.
Publicado: (2017)

The association of findings on brain computed tomography with neurologic outcomes following extracorporeal cardiopulmonary resuscitation
por: Ryu, Jeong-Am, et al.
Publicado: (2017)

Duration of sweep gas off trial for weaning from venovenous extracorporeal membrane oxygenation
por: Na, Soo Jin, et al.
Publicado: (2019)

Prognostic value of computed tomography score in patients after extracorporeal cardiopulmonary resuscitation
por: Ryu, Jeong-Am, et al.
Publicado: (2018)

Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation
por: Park, So Jin, et al.
Publicado: (2015)

Community versus hospital-acquired pneumonia in patients requiring extracorporeal membrane oxygenation
por: Park, Chul, et al.
Publicado: (2019)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

Nosocomial infections in in-hospital cardiac arrest patients who undergo extracorporeal cardiopulmonary resuscitation
por: Ko, Ryoung-Eun, et al.
Publicado: (2020)

Prognostic significance of respiratory quotient in patients undergoing extracorporeal cardiopulmonary resuscitation in Korea
por: Lee, Yun Im, et al.
Publicado: (2023)

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
por: Fisser, Christoph, et al.
Publicado: (2021)

Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2015)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support
por: Menk, Mario, et al.
Publicado: (2017)

Argatroban for heparin-induced thrombocytopenia therapy in ICU patients with sepsis or multiple organ dysfunction syndrome
por: Saugel, B, et al.
Publicado: (2009)

In vitro Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia
por: Nygaard, Søren, et al.
Publicado: (2023)

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia
por: Deen, Imad U., et al.
Publicado: (2022)

Anticoagulation with Argatroban in a Patient with Heparin-Induced Thrombocytopenia and Renal Insufficiency Undergoing Orthotopic Heart Transplantation
por: Green, Michael Stuart, et al.
Publicado: (2021)

Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia
por: Marchetti, Matteo, et al.
Publicado: (2022)

The Impact of Hypoxic Hepatitis on Clinical Outcomes after Extracorporeal Cardiopulmonary Resuscitation
por: Lee, Yun Im, et al.
Publicado: (2020)

Argatroban/azd-1222/dexamethasone: Thrombotic thrombocytopenia and lack of efficacy: 3 case reports
Publicado: (2021)

Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis
por: Colarossi, Giorgia, et al.
Publicado: (2021)

Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
por: Saugel, Bernd, et al.
Publicado: (2010)

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect?
por: Nakagawa, Tetsuya
Publicado: (2008)

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
por: Guetl, Katharina, et al.
Publicado: (2021)

Implementation of Venoarterial Extracorporeal Membrane Oxygenation in Nonintubated Patients
por: Kim, Hyeon A, et al.
Publicado: (2021)

Correction: Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
por: Saugel, Bernd, et al.
Publicado: (2012)

Predictors of neurological outcomes after successful extracorporeal cardiopulmonary resuscitation
por: Ryu, Jeong-Am, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2583t4fplsto2tabejnnt29400